Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Aggressive Multiple Sclerosis - whom, when and how.
No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patients.
KATP Channel Opener Diazoxide Prevents Neurodegeneration: A New Mechanism of Action via Antioxidative Pathway Activation.
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model.
Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability.
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination.
Stabilometric assessment of context dependent balance recovery in persons with multiple sclerosis: a randomized controlled study.
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection.
Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T.
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran.
Isolated cognitive relapses in multiple sclerosis.
Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.
Evaluation of a multiple sclerosis cluster among nurses in an inpatient oncology ward.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
Intestinal Microbiota as Modulators of the Immune System and Neuroimmune System: Impact on the Host Health and Homeostasis.
Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis.
Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis.
The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis.
Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7β-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of α-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3).
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis.
Impaired toll-like receptor 8 signaling in multiple sclerosis.
Pages
« first
‹ previous
…
361
362
363
364
365
366
367
368
369
…
next ›
last »